AMATO, MARIA PIA

AMATO, MARIA PIA  

Neuroscienze, Area del Farmaco e Salute del Bambino (NEUROFARBA)  

Mostra records
Risultati 1 - 20 di 384 (tempo di esecuzione: 0.027 secondi).
Titolo Data di pubblicazione Autore(i) File
"Brain reserve" and "cognitive reserve" should always be taken into account when studying neurodegeneration - Commentary 2018 Amato, MP;
250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study. 2009 O'Connor, P; Filippi, M; Arnason, B; Comi, G; Cook, S; Goodin, D; Hartung, Hp; Jeffery, D; Kappos, L; Boateng, F; Filippov, V; Groth, M; Knappertz, V; Kraus, C; Sandbrink, R; Pohl, C; Bogumil, T; Amato, Mp
A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis. 2015 Kuhle, J; Hardmeier, M; Baum, K; Amato, Mp; Buttmann, M
A case of Takotsubo syndrome during a multiple sclerosis brainstem relapse 2018 Prestipino, Elio; Squitieri, Martina; Razzolini, Lorenzo; Pastò, Luisa; Forleo, Paolo; Amato, Maria Pia
A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients 2015 Niccolai, Claudia; Portaccio, Emilio; Goretti, Benedetta; Hakiki, Bahia; Giannini, Marta; Pastò, Luisa; Righini, Isabella; Falautano, Monica; Minacapelli, Eleonora; Martinelli, Vittorio; Incerti, Chiara; Nocentini, Ugo; Fenu, Giuseppe; Cocco, Eleonora; Marrosu, Maria Giovanna; Garofalo, Elisa; Ambra, Ferdinando Ivano; Maddestra, Maurizio; Consalvo, Marilena; Viterbo, Rosa Gemma; Trojano, Maria; Losignore, Nunzia Alessandra; Zimatore, Giovanni Bosco; Pietrolongo, Erika; Lugaresi, Alessandra; Pippolo, Lorena; Roscio, Marco; Ghezzi, Angelo; Castellano, Debora; Stecchi, Sergio; Amato, Maria Pia
A double blind, placebo-controlled, phase II, add-on study of cyclophosphamide (CTX) for 24 months in patients affected by multiple sclerosis on a background therapy with interferon-beta study denomination: CYCLIN. 2004 F. Patti; M. P. Amato; M. Filippi; P. Gallo; M. Trojano; G. C. Comi
A method to compare prospective and historical cohorts to evaluate drug effects. Application to the analysis of early treatment effectiveness of intramuscular interferon-β1a in multiple sclerosis patients 2020 Mallucci G.; Patti F.; Brescia Morra V.; Buccafusca M.; Moiola L.; Amato M.P.; Ferraro E.; Trojano M.; Zaffaroni M.; Mirabella M.; Moscato G.; Plewnia K.; Zipoli V.; Puma E.; Bergamaschi R.
A new paraplegin mutation in a patient with primary progressive multiple sclerosis 2020 Bellinvia A.; Pasto L.; Niccolai C.; Tessa A.; Carrai R.; Martinelli C.; Moretti M.; Amato M.P.; Santorelli F.M.; Sorbi S.; Mata S.
A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis. 2010 Giovannoni G; Comi G; Cook S; Rammohan K; Rieckmann P; Soelberg Sørensen P; Vermersch P; Chang P; Hamlett A; Musch B; Greenberg SJ; MP. Amato; CLARITY Study Group.
A prospective study on the natural history of multiple sclerosis: clues to the conduct and interpretation of clinical trials. 1999 M. P. Amato; G. Ponziani; M. L. Bartolozzi; G. Siracusa
A prospective study on the prognosis of multiple sclerosis. 2000 M. P. Amato; G. Ponziani
A prospective, randomized, controlled trial of autologus haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper. 2012 Saccardi R, Freedman MS; Sormani, Mp; Atkins, H; Fsrge, D; Griffith, Lm; Kraft, G; Gl, Mancardi; Nash, R; Pasquini, M; Martin, R; Amato, Mp
A quality network model for the daily care of multiple sclerosis. 2000 L. D. Blumhardt; B. J. D. Vermeij; M. P. Amato; O. Andersen; G. Edan; O. Fernandez; M. Filippi; J. Haas; O. R. Hommes; P. Rieckmann
A short version of Rao's Brief Repeatable Battery as a screening tool for cognitive impairment in multiple sclerosis. 2009 Portaccio, E;Goretti, B;Zipoli, V;Siracusa, G;Sorbi, S;Amato, MP
A steroid-induced bilateral avascular necrosis of the femoral head in an underage patient affected by multiple sclerosis 2015 Carulli, Christian; Nistri, Lorenzo; Bracco, Laura; Giannini, Marta; Amato, Maria Pia
Abnormal cerebellar functional MRI connectivity in patients with paediatric multiple sclerosis. 2015 Cirillo, S; Rocca, Ma; Ghezzi, A; Valsasina, P; Moiola, L; Veggiotti, P; Amato, Mp; Comi, G; Falini, A; Filippi, M.
Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-beta 2006 ANNUNZIATA P; GIORGIO A; DE SANTI L; ZIPOLI V; PORTACCIO E; M.P. AMATO; CLERICI R; SCARPINI E; MOSCATO G; IUDICE A; VACCA G; OREFICE G; MORRA VB; MAIMONE D
Accuracy of self-assessment of the minimal record of disability in patients with multiple sclerosis. 1993 A. Solari; M. P. Amato; R. Bergamaschi; G. Logroscino; A. Citterio; D. Bochicchio; G. Filippini
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone 2011 Martinelli, V; Cocco, E; Capra, R; Salemi, G; Gallo, P; Capobianco, M; Pesci, I; Ghezzi, A; Pozzilli, C; Lugaresi, A; Bellantonio, P; Amato, Mp; Grimaldi, Lm; Trojano, M; Mancardi, Gl; Bergamaschi, R; Gasperini, C; Rodegher, M; Straffi, L; Ponzio, M; Comi, G
Adverse events after endovascular treatment of chronic cerebro-spinal venous insufficiency (CCSVI) in patients with multiple sclerosis. 2013 A. Ghezzi;P. Annovazzi;M. P. Amato;E. Capello;P. Cavalla;E. Cocco;M. Falcini;A. Gallo;F. Patti;P. Perini;M. E. Rodegher;M. Rovaris;M. R. Rottoli;G. Comi;M. S. Study